Correlation Between NewAmsterdam Pharma and Addex Therapeutics
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Addex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Addex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Addex Therapeutics, you can compare the effects of market volatilities on NewAmsterdam Pharma and Addex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Addex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Addex Therapeutics.
Diversification Opportunities for NewAmsterdam Pharma and Addex Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NewAmsterdam and Addex is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Addex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Addex Therapeutics and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Addex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Addex Therapeutics has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Addex Therapeutics go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and Addex Therapeutics
Given the investment horizon of 90 days NewAmsterdam Pharma is expected to under-perform the Addex Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, NewAmsterdam Pharma is 2.28 times less risky than Addex Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The Addex Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 937.00 in Addex Therapeutics on September 1, 2024 and sell it today you would lose (66.00) from holding Addex Therapeutics or give up 7.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NewAmsterdam Pharma vs. Addex Therapeutics
Performance |
| Timeline |
| NewAmsterdam Pharma |
| Addex Therapeutics |
NewAmsterdam Pharma and Addex Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NewAmsterdam Pharma and Addex Therapeutics
The main advantage of trading using opposite NewAmsterdam Pharma and Addex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Addex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will offset losses from the drop in Addex Therapeutics' long position.| NewAmsterdam Pharma vs. Monte Rosa Therapeutics | NewAmsterdam Pharma vs. Inventiva Sa | NewAmsterdam Pharma vs. Cullinan Oncology LLC | NewAmsterdam Pharma vs. Compass Therapeutics |
| Addex Therapeutics vs. Innate Pharma | Addex Therapeutics vs. Aptorum Group Ltd | Addex Therapeutics vs. Dyadic International | Addex Therapeutics vs. Soligenix |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |